Shao‐Hao Chen
Impact in
- Urology top 2%
- Urological Disorders and Treatments
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Prostate Cancer Treatment and Research 23
- Prostate Cancer Diagnosis and Treatment 18
- Renal cell carcinoma treatment 14
- Ferroptosis and cancer prognosis 11
- Co-authors
- Ning Xu (76 shared papers)Xue‐Yi Xue (74 shared papers)Qing‐Shui Zheng (66 shared papers)Yong Wei (61 shared papers)Yu‐Peng Wu (45 shared papers)Zhi‐Bin Ke (39 shared papers)Yun‐Zhi Lin (22 shared papers)Jin‐Bei Huang (17 shared papers)
- Journals
- Journal of Cancer (5 papers)Cell Death and Disease (3 papers)Frontiers in Oncology (3 papers)BioMed Research International (3 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- China
In The Last Decade
Shao‐Hao Chen
77 papers receiving 884 citations
Peers
Comparison fields: 5 of 68
- Urology 159
- Cancer Research 252
- Pulmonary and Respiratory Medicine 442
- Rheumatology 118
- Molecular Biology 375
Countries citing papers authored by Shao‐Hao Chen
This map shows the geographic impact of Shao‐Hao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Hao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Hao Chen more than expected).
Fields of papers citing papers by Shao‐Hao Chen
This network shows the impact of papers produced by Shao‐Hao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Hao Chen. The network helps show where Shao‐Hao Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shao‐Hao Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 51 | |
| 2 | 2019 | 46 | |
| 3 | 2016 | 40 | |
| 4 | 2019 | 34 | |
| 5 | 2020 | 31 | |
| 6 | 2016 | 29 | |
| 7 | 2018 | 24 | |
| 8 | 2018 | 24 | |
| 9 | 2016 | 24 | |
| 10 | 2020 | 23 | |
| 11 | 2017 | 23 | |
| 12 | 2019 | 21 | |
| 13 | 2021 | 20 | |
| 14 | 2018 | 20 | |
| 15 | 2021 | 19 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 19 | |
| 18 | 2018 | 18 | |
| 19 | 2016 | 18 | |
| 20 | Fasudil inhibits proliferation and collagen synthesis and induces apoptosis of human fibroblasts derived from urethral scar via the Rho/ROCK signaling pathway. | 2017 | 17 |
About Shao‐Hao Chen
Shao‐Hao Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research and Urology, having authored 80 papers that have together received 890 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Bladder and Urothelial Cancer Treatments (15 papers), Renal cell carcinoma treatment (14 papers), Ferroptosis and cancer prognosis (11 papers), Urinary and Genital Oncology Studies (10 papers), Urological Disorders and Treatments (10 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Urology (159 citations), Cancer Research (252 citations), Pulmonary and Respiratory Medicine (442 citations), Rheumatology (118 citations) and Molecular Biology (375 citations). Shao‐Hao Chen has collaborated with scholars based in China. Frequent co-authors include Ning Xu, Xue‐Yi Xue, Qing‐Shui Zheng, Yong Wei, Yu‐Peng Wu, Zhi‐Bin Ke, Yun‐Zhi Lin, Jin‐Bei Huang, Hai Cai and Xiaodong Li. Their work appears in journals such as Journal of Cancer, Cell Death and Disease, Frontiers in Oncology, BioMed Research International and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.